Suchergebnisse
10
Alles
Such-Filter
Tag
gene therapy
Point-of-Care (PoC) Cell and Gene Therapy Manufacturing Market Analysis 2025-2035: Focus on Technology, Therapeutic Area, End User and Region
28. März 2025 05:07 ET
|
Research and Markets
Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and...
Cell & Gene Therapies in Gastrointestinal Disorders Therapeutic Analysis Report 2024: Sales are Forecast to Reach $187 Million by 2030
26. März 2025 11:54 ET
|
Research and Markets
Dublin, March 26, 2025 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapies in Gastrointestinal Disorders: Therapeutic Analysis" report has been added to ResearchAndMarkets.com's offering.Both...
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
24. März 2025 07:00 ET
|
Lexeo Therapeutics
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
20. März 2025 16:05 ET
|
Vor Biopharma
VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second half of 2025 Anticipate initiation of the first trem-cel+VCAR33 Treatment...
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies
18. März 2025 09:00 ET
|
Oribiotech Ltd
Oribiotech Ltd. (Ori), announced the launch of its Preferred Partner Network (PPN), bringing together top AMCs and CDMOs.
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema
18. März 2025 08:02 ET
|
Ocugen
OCU200 has a very favorable safety and tolerability profileNo serious adverse events related to the study drug have been reportedDosing of the second cohort has been approved MALVERN, Pa., March 18,...
Purespring Therapeutics appoints Haseeb Ahmad as Chief Executive Officer
12. März 2025 03:00 ET
|
Purespring Therapeutics
Haseeb Ahmad brings over 25 years of leadership experience in life sciences, most recently serving as President of Novartis Europe and will lead the Company as it advances pioneering kidney disease...
Gene Therapy Market Global Forecast to 2032: Biopharma Giants Lead Gene Therapy Market Expansion – Latest Developments & Projections
07. März 2025 04:09 ET
|
Research and Markets
Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Market by Type (Gene Silencing), Vector (Viral (Retroviral, AAV), Non-Viral (Oligonucleotide)), Gene Type (Receptors, Cytokine),...
Gene Therapy Collaboration and Licensing Agreements Trends Report and Directory 2024: Comprehensive Access to 770 Deals Announced Since 2016 - Upfront, Milestone, Royalties Terms
06. März 2025 11:05 ET
|
Research and Markets
Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight
05. März 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight The growing incidence of genetic disorders and...